SMTL ID : 9gwz.3 (3 other biounits)

Crystal structure of 23ME-00610 Fab

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.12 Å

Oligo State

hetero-1-1-mer

Ligands

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.1: 5 residues within 4Å: Chain A: R.99, T.102, V.104 Chain B: Y.53, R.54 Ligand excluded by PLIP CL.5: 4 residues within 4Å: Chain A: F.27, S.28, N.31, Y.32 Ligand excluded by PLIP

2 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.2: 6 residues within 4Å: Chain A: V.92, Q.110, G.111, T.112, L.113, P.154 3 PLIP interactions: 2 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:L.113 Water bridges: A:Q.110, B:G.45 PO4.4: 5 residues within 4Å: Chain A: V.168, H.169 Chain B: T.168, E.169, D.171 6 PLIP interactions: 5 interactions with chain B, 1 interactions with chain A Hydrogen bonds: B:T.168, B:D.171 Water bridges: B:D.171, B:D.171, B:S.172 Salt bridges: A:H.169

1 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)

MPD.3: 4 residues within 4Å: Chain A: L.101 Chain B: F.36, S.95, N.96 2 PLIP interactions: 1 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:L.101 Hydrophobic interactions: B:F.36

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Melero, C. et al., CD200R1 immune checkpoint blockade by the first-in-human anti-CD200R1 antibody 23ME-00610: molecular mechanism and engineering of a surrogate antibody. Mabs (2024)

Release Date

2024-10-23

Peptides

23ME-00610 Fab (heavy): A
23ME-00610 Fab (light): B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
CCC

B
DDD

23ME-00610 Fab (heavy)

23ME-00610 Fab (light)

Related Entries With Identical Sequence